The correlation between membranous-cytoplasmic and nuclear EGFR expression, and the favorable survival outcome in CCRCC patients with nuclear EGFR overexpression, could be an added value in selecting CCRCC patients with different outcomes. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.